Glutamatergic system abnormalities in posttraumatic stress disorder

Psychopharmacology

Volumn 232, Issue 23, 2015, Pages 4261-4268

  Nishi, Daisuke ^a,b   Hashimoto, Kenji ^b,c   Noguchi, Hiroko ^a,b   Hamazaki, Kei ^b,d   Hamazaki, Tomohito ^b,e   Matsuoka, Yutaka ^a,b  

^a NATIONAL HOSPITAL ORGANIZATION DISASTER MEDICAL CENTER   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

^e Toyama Jonan Onsen Daini Hospital   (Japan)

Author keywords

Accident; Depression; Glutamate; Glutamine; Posttraumatic stress disorder

Indexed keywords

DEXTRO SERINE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; SERINE; BIOLOGICAL MARKER;

ADULT; AMINO ACID BLOOD LEVEL; ANXIETY ASSESSMENT; ARTICLE; CASE CONTROL STUDY; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IMPACT OF EVENTS SCALE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PATHOGENESIS; POSTTRAUMATIC STRESS DISORDER; POSTTRAUMATIC STRESS DISORDER SCALE; PRIORITY JOURNAL; RISK ASSESSMENT; UNIVARIATE ANALYSIS; BLOOD; CONTROLLED STUDY; DEPRESSIVE DISORDER, MAJOR; DOUBLE BLIND PROCEDURE; FOLLOW UP; MIDDLE AGED; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; STRESS DISORDERS, POST-TRAUMATIC;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GLUTAMIC ACID; GLUTAMINE; HUMANS; MALE; MIDDLE AGED; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84945441188     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-015-4052-5     Document Type: Article

References (48)

1. Altamura CA, Mauri MC, Ferrara A, Moro AR, D'Andrea G, Zamberlan F (1993) Plasma and platelet excitatory amino acids in psychiatric disorders. Am J Psychiatry 150:1731-1733
2. Association AP (2000) American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Text Revision; DSM-IV-TR, Fourth Editionth edn. American Psychiatric Association, Washington DC
3. Asukai N, Kato H, Kawamura N, Kim Y, Yamamoto K, Kishimoto J, Miyake Y, Nishizono-Maher A (2002) Reliability and validity of the Japanese-language version of the impact of event scale-revised (IES-R-J): four studies of different traumatic events. J Nerv Ment Dis 190:175-182
4. Asukai N, Hirohata S, Kato H, Konishi T (2003) Psychometric properties of the Japanese-language version of the Clinician-Administered PTSD Scale for DSM-IV (in Japanese). Jpn J Trauma Stress 1:47-53
5. Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F (2000) Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 47:305-313
6. Baker SP, O'Neill B (1976) The injury severity score: an update. J Trauma 16:882-885
7. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM (1995) The development of a Clinician-Administered PTSD Scale. J Trauma Stress 8:75-90
8. Brewin CR, Andrews B, Valentine JD (2000) Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol 68:748-766
9. Chambers RA, Bremner JD, Moghaddam B, Southwick SM, Charney DS, Krystal JH (1999) Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation. Sem Cli Neuropsychiatr 4:274-281
10. Coyle JT, Leski M, Morrison JH (2002) The diverse roles of L-glutamic acid in brain signal transduction. In: Davis KL, Charney DS, Coyle JT, Nemeroff CB (eds) Neuropsychopharmacology - the fifth generation of progress. Lippincott Williams & Wilkins, Philadelphia, pp 71-90
11. Davidson JR, Hughes D, Blazer DG, George LK (1991) Post-traumatic stress disorder in the community: an epidemiological study. Psychol Med 21:713-721
12. Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, Kirkwood K, Aan Het Rot M, Lapidus KA, Wan LB, Iosifescu D, Charney DS (2014) Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry 71:681-688
13. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
14. Fukushima T, Kawai J, Imai K, Toyo'oka T (2004) Simultaneous determination of D- and L-serine in rat brain microdialysis sample using a column-switching HPLC with fluorimetric detection. Biomed Chromatogr: BMC 18:813-819
15. Hashimoto K (2009) Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev 61:105-123
16. Hashimoto K (2014) Targeting of NMDA receptors in new treatments for schizophrenia. Expert Opin Ther Targets 18:1049-1063
17. Hashimoto K, Engberg G, Shimizu E, Nordin C, Lindstrom LH, Iyo M (2005) Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients. BMC Psychiatry 5:6
18. Hashimoto K, Sawa A, Iyo M (2007) Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 62:1310-1316
19. Hashimoto K, Sasaki T, Kishimoto A (2013) Old drug ifenprodil, new hope for PTSD with a history of childhood abuse. Psychopharmacology 227:375-376
20. Hassel B, Dingledine R (2006) Glutamate. In: Siegel GJ, Albers RW, Brady ST, Price DL (eds) Basic neurochemistry molecular, cellular, and medical aspects, 7th edn. Elsevier Academic Press, Burlington, pp 267-290
21. Hertzberg MA, Butterfield MI, Feldman ME, Beckham JC, Sutherland SM, Connor KM, Davidson JR (1999) A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry 45:1226-1229
22. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995) Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 52:1048-1060
23. Kim JS, Schmid-Burgk W, Claus D, Kornhuber HH (1982) Increased serum glutamate in depressed patients. Archiv fur Psychiatrie und Nervenkrankheiten 232:299-304
24. Kishimoto A, Kaneko M, Gotoh Y, Hashimoto K (2012) Ifenprodil for the treatment of flashbacks in female posttraumatic stress disorder patients with a history of childhood sexual abuse. Biol Psychiatry 71:e7-e8
25. Kugaya A, Akechi T, Okuyama T, Okamura H, Uchitomi Y (1998) Screening for psychological distress in Japanese cancer patients. Jpn J Clin Oncol 28:333-338
26. Levine J, Panchalingam K, Rapoport A, Gershon S, McClure RJ, Pettegrew JW (2000) Increased cerebrospinal fluid glutamine levels in depressed patients. Biol Psychiatry 47:586-593
27. Matsuoka Y, Nishi D, Nakajima S, Yonemoto N, Hashimoto K, Noguchi H, Homma M, Otomo Y, Kim Y (2009) The Tachikawa cohort of motor vehicle accident study investigating psychological distress: design, methods and cohort profiles. Soc Psychiatry Psychiatr Epidemiol 44:333-340
28. Matsuoka Y, Nishi D, Yonemoto N, Hamazaki K, Matsumura K, Noguchi H, Hashimoto K, Hamazaki T (2013) Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial. BMC Psychiatry 13:8
29. Matsuoka Y, Nishi D, Hamazaki K, Yonemoto N, Matsumura K, Noguchi H, Hashimoto K, Hamazaki T (2015) Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial. J Clin Psychiatry
30. Mauri MC, Ferrara A, Boscati L, Bravin S, Zamberlan F, Alecci M, Invernizzi G (1998) Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment. Neuropsychobiology 37:124-129
31. Meyerhoff DJ, Mon A, Metzler T, Neylan TC (2014) Cortical gamma-aminobutyric acid and glutamate in posttraumatic stress disorder and their relationships to self-reported sleep quality. Sleep 37:893-900
32. Mitani H, Shirayama Y, Yamada T, Maeda K, Ashby CR Jr, Kawahara R (2006) Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 30:1155-1158
33. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatr: J Ment Sci 134:382-389
34. Myers KM, Carlezon WA Jr, Davis M (2011) Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 36:274-293
35. Nishi D, Noguchi H, Yonemoto N, Nakajima S, Kim Y, Matsuoka Y (2013) Incidence and prediction of post-traumatic stress disorder at 6 months after motor vehicle accidents in Japan. Psychosomatics 54:263-271
36. Otsubo T, Tanaka K, Koda R, Shinoda J, Sano N, Tanaka S, Aoyama H, Mimura M, Kamijima K (2005) Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview. Psychiatry Clin Neurosci 59:517-526
37. Ozer EJ, Best SR, Lipsey TL, Weiss DS (2003) Predictors of posttraumatic stress disorder and symptoms in adults: a meta-analysis. Psychol Bull 129:52-73
38. Palsson E, Jakobsson J, Sodersten K, Fujita Y, Sellgren C, Ekman CJ, Agren H, Hashimoto K, Landen M (2014) Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol
39. Pennington DL, Abe C, Batki SL, Meyerhoff DJ (2014) A preliminary examination of cortical neurotransmitter levels associated with heavy drinking in posttraumatic stress disorder. Psychiatry Res 224:281-287
40. Riaza Bermudo-Soriano C, Perez-Rodriguez MM, Vaquero-Lorenzo C, Baca-Garcia E (2012) New perspectives in glutamate and anxiety. Pharmacol Biochem Behav 100:752-774
41. Sasaki T, Hashimoto K, Okawada K, Tone J, Machizawa A, Tano A, Nakazato M, Iyo M (2013) Ifenprodil for the treatment of flashbacks in adolescent female posttraumatic stress disorder patients with a history of abuse. Psychother Psychosom 82:344-345
42. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22-33, quiz 34-57
43. Sitges M, Chiu LM, Guarneros A, Nekrassov V (2007) Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings. Neuropharmacology 52:598-605
44. Takahashi N, Tomita K, Higuchi T, Inada T (2004) The inter-rater reliability of the Japanese version of the Montgomery-Asberg depression rating scale (MADRS) using a structured interview guide for MADRS (SIGMA). Human Psychopharmacol 19:187-192
45. Walker EA, Katon W, Russo J, Ciechanowski P, Newman E, Wagner AW (2003) Health care costs associated with posttraumatic stress disorder symptoms in women. Arch Gen Psychiatry 60:369-374
46. Weiss DS (2004) The Impact of Event Scale-Revised, Second editionth edn. Guilford Press, New York
47. Zatzick DF, Russo J, Pitman RK, Rivara F, Jurkovich G, Roy-Byrne P (2005) Reevaluating the association between emergency department heart rate and the development of posttraumatic stress disorder: a public health approach. Biol Psychiatry 57:91-95
48. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370